On behalf of IGEA Pharma N.V. (the “Company”), it is a pleasure to invite you to attend the Annual General Meeting on 6 June 2019 (the “AGM”). The meeting will be held at Hoofddorp Transpolis, Polarisavenue 1, 2123 JH Hoofddorp, the Netherlands. The meeting will start at 10.00 am. CET.
The topics to be discussed at the AGM are set out in the agenda together with the explanatory notes. You can find the agenda and other related documents and further information regarding registration and voting by proxy on our website at https://www.igeapharma.nl/investors-relations/, section ‘Information for Shareholders’. These documents are also available at the Company’s offices at Siriusdreef 17, 2132 WT Hoofddorp, the Netherlands (the “Company’s Offices”).
You are entitled to participate in and vote at the AGM if you have these rights on 9 May 2019 at 6:00 pm CET and are registered as such in one of the registers designated by the Company’s Management Board, provided that you have registered for the AGM in accordance with the provisions set forth below.
If you wish to attend the AGM either in person or by proxy, we kindly request you to notify Van Lanschot N.V./Kempen & Co N.V. by e-mail to email@example.com or the Company through your bank or stockbroker. Notification can take place as of today, but no later than 30 May 2019 5:00 pm CET. All attendees must be prepared to show a valid proof of identity for admittance.
Voting by proxy
Shareholders who do not wish to attend the AGM in person may grant a proxy to either (i) Mr Diego Mortillaro, or (ii) Mr A.J. Wiggers, civil law notary at DLA Piper Nederland N.V., or his deputy, as independent third party or (iii) another person, to vote at the AGM on the shareholders’ behalf. The duly signed proxy instrument needs to be received by no later than 30 May 2019, 5:00 pm CET at Van Lanschot N.V./Kempen & Co N.V., Beethovenstraat 300, 1077 WZ Amsterdam and e-mail to firstname.lastname@example.org or at the Company’s Offices. Prior to the AGM, the proxy holder shall hand in the admission ticket and a copy of the proxy instrument at the registration desk.
For further information, please contact me at the Company’s Offices or via e-mail at email@example.com.
I look forward to your participation on 6 June 2019.
On behalf of the Management Board,
Chief Executive Officer
Hoofddorp, 7 May 201
Documents for download:
IGEA Pharma NV_Convening notice agm 6 June 2019
IGEA Pharma NV_Agenda and explanatory notes agm 6 June 2019
IGEA Pharma NV_Proxy form agm 6 June 2019